Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167


Pathology of Neonatal Non- albicans Candidiasis: Autopsy Study and Literature Review.

Hemedez C, Trail-Burns E, Mao Q, Chu S, Shaw SK, Bliss JM, De Paepe ME.

Pediatr Dev Pathol. 2018 Sep 7:1093526618798773. doi: 10.1177/1093526618798773. [Epub ahead of print]


Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.

Batten LM, Bhattacharya IS, Moretti L, Haviland JS, Emson MA, Miller SE, Jefford M, MacKenzie M, Wilcox M, Hyslop M, Todd R, Snowdon CF, Bliss JM.

Res Involv Engagem. 2018 Jul 16;4:22. doi: 10.1186/s40900-018-0108-0. eCollection 2018.


Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.

Blok EJ, Engels CC, Dekker-Ensink G, Meershoek-Klein Kranenbarg E, Putter H, Smit VTHBM, Liefers GJ, Morden JP, Bliss JM, Coombes RC, Bartlett JMS, Kroep JR, van de Velde CJH, Kuppen PJK.

Breast Cancer Res Treat. 2018 May 15. doi: 10.1007/s10549-018-4785-z. [Epub ahead of print]


Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.

Tutt A, Tovey H, Cheang MCU, Kernaghan S, Kilburn L, Gazinska P, Owen J, Abraham J, Barrett S, Barrett-Lee P, Brown R, Chan S, Dowsett M, Flanagan JM, Fox L, Grigoriadis A, Gutin A, Harper-Wynne C, Hatton MQ, Hoadley KA, Parikh J, Parker P, Perou CM, Roylance R, Shah V, Shaw A, Smith IE, Timms KM, Wardley AM, Wilson G, Gillett C, Lanchbury JS, Ashworth A, Rahman N, Harries M, Ellis P, Pinder SE, Bliss JM.

Nat Med. 2018 May;24(5):628-637. doi: 10.1038/s41591-018-0009-7. Epub 2018 Apr 30.


Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer.

Mills J, Haviland JS, Moynihan C, Bliss JM, Hopwood P; START Trial Management Group.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):433-441. doi: 10.1016/j.clon.2018.03.007. Epub 2018 Apr 10.


Dietary Supplementation with Medium-Chain Triglycerides Reduces Candida Gastrointestinal Colonization in Preterm Infants.

Arsenault AB, Gunsalus KTW, Laforce-Nesbitt SS, Przystac L, DeAngelis EJ, Hurley ME, Vorel ES, Tucker R, Matthan NR, Lichtenstein AH, Kumamoto CA, Bliss JM.

Pediatr Infect Dis J. 2018 Mar 24. doi: 10.1097/INF.0000000000002042. [Epub ahead of print]


Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.

O'Leary B, Hrebien S, Morden JP, Beaney M, Fribbens C, Huang X, Liu Y, Bartlett CH, Koehler M, Cristofanilli M, Garcia-Murillas I, Bliss JM, Turner NC.

Nat Commun. 2018 Mar 1;9(1):896. doi: 10.1038/s41467-018-03215-x.


Role of the inducible adhesin, CpAls7, in binding of Candida parapsilosis to extracellular matrix under fluid shear.

Neale MN, Glass KA, Longley SJ, Kim DJ, Laforce-Nesbitt SS, Wortzel JD, Shaw SK, Bliss JM.

Infect Immun. 2018 Jan 29. pii: IAI.00892-17. doi: 10.1128/IAI.00892-17. [Epub ahead of print]


Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?

Bhattacharya IS, Kirby AM, Bliss JM, Coles CE.

Clin Oncol (R Coll Radiol). 2018 Mar;30(3):158-165. doi: 10.1016/j.clon.2017.12.022. Epub 2018 Jan 10.


Targeted radiotherapy for early breast cancer - Authors' reply.

Coles CE, Haviland JS, Kirby AM, Titley J, Wilcox M, Bliss JM, Yarnold JR.

Lancet. 2018 Jan 6;391(10115):27-28. doi: 10.1016/S0140-6736(17)33317-2. No abstract available.


Editorial: The Neonatal Immune System: A Unique Host-Microbial Interface.

Bliss JM, Wynn JL.

Front Pediatr. 2017 Dec 21;5:274. doi: 10.3389/fped.2017.00274. eCollection 2017. No abstract available.


Growth and Neurodevelopmental Outcomes of Early, High-Dose Parenteral Amino Acid Intake in Very Low Birth Weight Infants: A Randomized Controlled Trial.

Balakrishnan M, Jennings A, Przystac L, Phornphutkul C, Tucker R, Vohr B, Stephens BE, Bliss JM.

JPEN J Parenter Enteral Nutr. 2017 Mar 1:148607117696330. doi: 10.1177/0148607117696330. [Epub ahead of print]


Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES.

Cheang MCU, Bliss JM, Viale G, Speirs V, Palmieri C, Shaaban A, L√łnning PE, Morden J, Porta N, Jassem J, van De Velde CJ, Rasmussen BB, Verhoeven D, Bartlett JMS, Coombes RC; PathIES Sub-Committee.

Breast Cancer Res Treat. 2018 Feb;168(1):169-178. doi: 10.1007/s10549-017-4543-7. Epub 2017 Nov 24.


Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.

Haviland JS, Mannino M, Griffin C, Porta N, Sydenham M, Bliss JM, Yarnold JR; START Trialists' Group.

Radiother Oncol. 2018 Jan;126(1):155-162. doi: 10.1016/j.radonc.2017.10.033. Epub 2017 Nov 15.


The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up.

Bhattacharya IS, Morden JP, Griffin C, Snowdon C, Brannan R, Bliss JM, Kilburn L.

Clin Oncol (R Coll Radiol). 2017 Dec;29(12):796-798. doi: 10.1016/j.clon.2017.10.007. Epub 2017 Oct 26. No abstract available.


Conducting non-commercial international clinical trials: the ICR-CTSU experience.

Fox L, Toms C, Kernaghan S, Snowdon C, Bliss JM.

Trials. 2017 Sep 26;18(1):440. doi: 10.1186/s13063-017-2176-0.


RNA-Seq reveals a central role for lectin, C1q and von Willebrand factor A domains in the defensive glue of a terrestrial slug.

Smith AM, Papaleo C, Reid CW, Bliss JM.

Biofouling. 2017 Oct;33(9):741-754. doi: 10.1080/08927014.2017.1361413. Epub 2017 Sep 13.


TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001).

Muller I, Kilburn LS, Taylor PN, Barrett-Lee PJ, Bliss JM, Ellis P, Ludgate ME, Dayan CM.

Eur Thyroid J. 2017 Jul;6(4):197-207. doi: 10.1159/000460246. Epub 2017 Apr 4.


Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.

Supplemental Content

Loading ...
Support Center